Effectiveness of OsteoKing in the Treatment of Lumbar Disc Herniation: A Randomized, Double‑Blind, Double‑Dummy, Positive‑Controlled, Multicenter Clinical Trial
Journal of Evidence-Based Medicine · 2026-06 · 19 (2)
DOI: 10.1111/jebm.70140 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Evidence-Based Medicine, online erschienen am 25.06.2026. Verfasst von Zhuoyun Wu und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, China. Hauptthemen laut MEDLINE: Intervertebral Disc Displacement, Lumbar Vertebrae, Drugs, Chinese Herbal. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Aim
This study aimed to evaluate the efficacy and safety of OsteoKing compared to a standard active comparator (Yaobitong capsules) for managing lumbar disc herniation (LDH).
Methods
A randomized, double‐blind, double‐dummy, positive‐controlled, multicenter trial was conducted across 17 hospitals in China. A total of 210 eligible patients with LDH were randomized in a 2:1 ratio to receive either OsteoKing ( n = 140) or Yaobitong capsules ( n = 70) for 4 weeks. The primary efficacy endpoint was the change in the Visual Analog Scale (VAS) score from baseline to week 4. Secondary endpoints included the Oswestry Disability Index score, the resolution rate of individual traditional Chinese medicine symptoms, and safety assessments. Missing data and repeated measures were handled using multiple imputation and a mixed‐model for repeated measures.
Results
Baseline characteristics were well‐matched between the two groups. At week 4, both groups experienced substantial improvements in pain and lumbar function. In the full analysis set (FAS), the between‐group least squares mean difference (LSMD) in VAS reduction was −0.37 (95% CI: −0.77 to 0.03; p = 0.074). In the per‐protocol set (PPS) analysis, the OsteoKing group achieved a significantly greater reduction in VAS scores compared to the control group (LSMD: −0.41, 95% CI: −0.82 to −0.01; p = 0.0453). Improvements in ODI scores were comparable between the groups in both the FAS and PPS analyses ( p > 0.05). Additionally, the OsteoKing group demonstrated significantly higher resolution rates for low back pain and fatigue/lassitude at week 4 ( p < 0.05). Both treatments were safe and well‐tolerated, with comparable incidence rates of adverse events (21.43% vs. 24.29%, p = 0.6396).
Conclusions
OsteoKing demonstrated comparable overall efficacy and safety to Yaobitong capsules in improving lumbar function and relieving symptoms in patients with LDH. Furthermore, OsteoKing may offer a modest, short‐term analgesic advantage at the 4‐week mark. OsteoKing represents a safe, effective, and viable conservative therapeutic option for LDH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, China.
- Engineering Research Center of Chinese Orthopaedics and Sports Rehabilitation Artificial Intelligence, Ministry of Education, Bejing, China.
- Department of Traumatology and Joint Surgery, Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, China.
- Department of Massage, Shanxi Provincial Hospital of Traditional Chinese Medicine, Taiyuan, China.
- Department of Orthopedics, Heilongjiang Provincial Hospital of Traditional Chinese Medicine, Harbin, China.
- Third Department of Orthopedics and Traumatology, Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang, China.
Zitieren
APA
Wu, Z., Dong, S., Ma, H., Ma, Y., Zhang, K., Wang, X., Wang, H., Du, S., Wu, W., Fan, T., Wei, J., Wang, W., Han, Y., Ma, C., Cheng, F., Pang, Y., Sun, R., Zhu, Z., Chen, L., …, & Chen, W. (2026). Effectiveness of OsteoKing in the Treatment of Lumbar Disc Herniation: A Randomized, Double‑Blind, Double‑Dummy, Positive‑Controlled, Multicenter Clinical Trial. Journal of Evidence-Based Medicine, 19(2). https://doi.org/10.1111/jebm.70140
Vancouver
Wu Z, Dong S, Ma H, Ma Y, Zhang K, Wang X, et al. Effectiveness of OsteoKing in the Treatment of Lumbar Disc Herniation: A Randomized, Double‑Blind, Double‑Dummy, Positive‑Controlled, Multicenter Clinical Trial. Journal of Evidence-Based Medicine. 2026;19(2). doi:10.1111/jebm.70140
BibTeX
@article{Wu2026,
author = {Wu, Zhuoyun and Dong, Shiyu and Ma, Hongqing and Ma, Yufeng and Zhang, Kuayue and Wang, Xuehui and Wang, Hao and Du, Shuangqing and Wu, Wenjie and Fan, Tao and Wei, Jian and Wang, Wenge and Han, Yue and Ma, Chao and Cheng, Fuhong and Pang, Yuan and Sun, Rongxin and Zhu, Ziqiang and Chen, Linlin and Fang, Wei and Liu, Xiangrong and Qing, Peidong and Mi, Baohong and Chen, Weiheng},
title = {Effectiveness of OsteoKing in the Treatment of Lumbar Disc Herniation: A Randomized, Double‑Blind, Double‑Dummy, Positive‑Controlled, Multicenter Clinical Trial},
journal = {Journal of Evidence-Based Medicine},
year = {2026},
volume = {19},
number = {2},
doi = {10.1111/jebm.70140}
}
EUVIMED